Administration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use
Joanna Gotfrit(Ottawa Hospital), Rachel Goodwin(University of Ottawa), Patricia A. Tang(Occupational Cancer Research Centre), Shahid Ahmed(Emory University), Haji Chalchal, Horia Marginean(Ottawa Hospital), Akmal Ghafoor(Windsor Regional Hospital), Petr Kavan(Université Paris Cité), Yoo-Joung Ko, Karen Mulder
Cited by 1
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
|Nature Reviews Clinical Oncology|2020|365